Dr. Reddy’s Laboratories introduces FDA-approved Nerivio for migraine management in India
Dr. Reddy’s Laboratories Ltd., a global pharmaceutical company, has announced the rollout of Nerivio in India. This state-of-the-art, United States Food and Drug Administration (USFDA) ... Read More
Dr. Reddy’s launches RGenX to enter trade generics business in India
Dr. Reddy's Laboratories, an Indian pharmaceutical company, has announced its entry into the trade generics business in India with the launch of a dedicated division ... Read More
Dr. Reddy’s to sell two anti-bacterial brands in Russia and CIS to Binnopharm
Dr. Reddy's Laboratories has agreed to divest anti-bacterial medicines under the Ciprolet and Levolet brands in Russia, Uzbekistan, and Belarus to Binnopharm Group, a Sistema ... Read More
Dr. Reddy’s to sell and distribute certain Novartis’ products in India
Dr. Reddy's Laboratories has signed an exclusive sales and distribution agreement with Novartis India Limited (NIL) for the latter’s Voveran range, the Calcium range and ... Read More
Dr. Reddy’s launches Minoxidil for treatment of female pattern hair loss
Dr. Reddy's Laboratories said that it has launched a prescription drug for the treatment of female pattern hair loss (FPHL) in the form of Minoxidil ... Read More
ICICI Lombard, Dr. Reddy’s partner to offer cashless outpatient services
ICICI Lombard General Insurance Company has entered into a partnership with SVAAS Wellness Limited, a fully-owned subsidiary of Dr. Reddy’s Laboratories Limited for launching a ... Read More